×
About 691 results

ALLMedicine Cystinuria Center

Research & Reviews  315 results

Re: Assessment of Health-Related Quality of Life in Patients with Cystinuria on Tiopron...
https://doi.org/10.1097/JU.0000000000001053.02
The Journal of Urology; Assimos DG

Apr 9th, 2020 - Re: Assessment of Health-Related Quality of Life in Patients with Cystinuria on Tiopronin Therapy.|2020|Assimos DG,|

α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.
https://doi.org/10.1542/peds.2019-2951
Pediatrics Cil O, Perwad F

Apr 4th, 2020 - Cystinuria is an autosomal recessive disorder characterized by excessive urinary excretion of cystine, resulting in recurrent cystine kidney stones, often presenting in childhood. Current treatment options for cystinuria include dietary and/or flu...

Tolvaptan treatment of cystine urolithiasis in a mouse model of cystinuria.
https://doi.org/10.1007/s00345-020-03166-3
World Journal of Urology; Bai Y, Tang Y et. al.

Mar 17th, 2020 - Cystinuria is an inherited disease characterized by increased urinary cystine excretion and recurrent cystine stones. Current treatment regimens have limited effectiveness in preventing stone recurrence and are often poorly tolerated. The aim of t...

Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus...
https://doi.org/10.1089/end.2019.0703
Journal of Endourology; Eisner BH, Goldfarb DS et. al.

Feb 18th, 2020 - Purpose: Cystinuria is a genetic disorder with both autosomal recessive and incompletely dominant inheritance. The disorder disrupts cystine and other dibasic amino acid transport in proximal tubules of the kidney, resulting in recurrent kidney st...

Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria
https://clinicaltrials.gov/ct2/show/NCT03663855

Jan 12th, 2020 - The purpose of this study is to determine the minimum effective dose of the cysteine binding thiol drug (CBTD) Tiopronin on urine cystine capacity, which is a measure of cystine solubility in the urine, in patients with cystinuria to evaluate the ...

see more →

Guidelines  1 results

Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets for the Treatment of Cystinuria
http://ir.retrophin.com/news-releases/news-release-details/retrophin-announces-fda-approval-thiolar-ec-tiopronin-100mg-and

Jun 27th, 2019 - Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of THIOLA® EC (tiopronin), a new enteric-coated formulation of THIOLA® (tiopronin), to be used for the treatmen...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  349 results

Penicillamine - penicillamine capsule-ANI Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df085d70-4f4f-425d-9a1b-8a6f7acd0011

May 25th, 2020 - Boxed Warning section Physicians planning to use penicillamine should thoroughly familiarized themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine should never be used casually. Each patient should r...

Re: Assessment of Health-Related Quality of Life in Patients with Cystinuria on Tiopron...
https://doi.org/10.1097/JU.0000000000001053.02
The Journal of Urology; Assimos DG

Apr 9th, 2020 - Re: Assessment of Health-Related Quality of Life in Patients with Cystinuria on Tiopronin Therapy.|2020|Assimos DG,|

α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.
https://doi.org/10.1542/peds.2019-2951
Pediatrics Cil O, Perwad F

Apr 4th, 2020 - Cystinuria is an autosomal recessive disorder characterized by excessive urinary excretion of cystine, resulting in recurrent cystine kidney stones, often presenting in childhood. Current treatment options for cystinuria include dietary and/or flu...

Tolvaptan treatment of cystine urolithiasis in a mouse model of cystinuria.
https://doi.org/10.1007/s00345-020-03166-3
World Journal of Urology; Bai Y, Tang Y et. al.

Mar 17th, 2020 - Cystinuria is an inherited disease characterized by increased urinary cystine excretion and recurrent cystine stones. Current treatment regimens have limited effectiveness in preventing stone recurrence and are often poorly tolerated. The aim of t...

Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus...
https://doi.org/10.1089/end.2019.0703
Journal of Endourology; Eisner BH, Goldfarb DS et. al.

Feb 18th, 2020 - Purpose: Cystinuria is a genetic disorder with both autosomal recessive and incompletely dominant inheritance. The disorder disrupts cystine and other dibasic amino acid transport in proximal tubules of the kidney, resulting in recurrent kidney st...

see more →

News  9 results

FDA OKs New Formulation of Tiopronin for Cystinuria
https://www.medscape.com/viewarticle/915140

Jul 1st, 2019 - The US Food and Drug Administration (FDA) has approved an enteric-coated delayed-release formulation of tiopronin (Thiola EC, Retrophin) for treatment of cystinuria, a rare inherited disorder that causes an increase in cystine levels in the urine,...

Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets for the Treatment of Cystinuria
http://ir.retrophin.com/news-releases/news-release-details/retrophin-announces-fda-approval-thiolar-ec-tiopronin-100mg-and

Jun 27th, 2019 - Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of THIOLA® EC (tiopronin), a new enteric-coated formulation of THIOLA® (tiopronin), to be used for the treatmen...

Imprimis Pharma to make cheaper alternative to Retrophin's Thiola
https://www.reuters.com/article/us-imprimis-drugpricing/imprimis-pharma-to-make-cheaper-alternative-to-retrophins-thiola-idUSKCN0VJ2D6

Feb 10th, 2016 - (Reuters) - Compounding pharmacy Imprimis Pharmaceuticals Inc said on Wednesday it plans to make a cheaper alternative to Retrophin Inc’s kidney stone drug, Thiola. Retrophin, under former Chief Executive Martin Shkreli, raised the price of the dr...

Paroxysmal Hemidyskinesia Related to a Large Thalamic Cyst
https://www.medscape.com/viewarticle/551277

Feb 13th, 2007 - Introduction Symptomatic thalamic lesions are more frequently related to stroke, usually causing contralateral sensory symptoms, and less often to contralateral movement disorders. Thalamic lesions leading to movement disorders have been reported ...

see more →

Patient Education  2 results see all →